Litcius/Paper detail

Covid-19: AstraZeneca says its antibody drug AZD7442 is effective for preventing and reducing severe illness

Elisabeth Mahase

2021BMJ27 citationsDOIOpen Access PDF

Abstract

Covid-19: AstraZeneca says its antibody drug AZD7442 is effective for preventing and reducing severe illness

Topics & Concepts

MedicineCoronavirus disease 2019 (COVID-19)DrugClinical trialInternal medicineIntensive care medicinePharmacologyDiseaseInfectious disease (medical specialty)SARS-CoV-2 and COVID-19 Research
Covid-19: AstraZeneca says its antibody drug AZD7442 is effective for preventing and reducing severe illness | Litcius